Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · IEX Real-Time Price · USD
12.40
-0.45 (-3.50%)
At close: May 23, 2024, 4:00 PM
12.41
+0.01 (0.08%)
After-hours: May 23, 2024, 5:15 PM EDT

Y-mAbs Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Y-mAbs Therapeutics stock have an average target of 17.14, with a low estimate of 5.00 and a high estimate of 26. The average target predicts an increase of 38.23% from the current stock price of 12.40.

Analyst Consensus: Buy
Target Low Average Median High
Price $5.00 $17.14 $22 $26
Change -59.68% +38.23% +77.42% +109.68%

Analyst Ratings

The average analyst rating for YMAB stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 333443
Buy 111221
Hold 332111
Sell 222222
Strong Sell 000000
Total 998997

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$21$22
Strong Buy Maintains $21$22 +77.42% May 13, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
n/a
Strong Buy Maintains n/a n/a Mar 6, 2024
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$22$26
Strong Buy Maintains $22$26 +109.68% Mar 4, 2024
BMO Capital
BMO Capital
Buy
Maintains
$16$26
Buy Maintains $16$26 +109.68% Mar 4, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$11$21
Strong Buy Maintains $11$21 +69.35% Feb 20, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
100.27M
from 84.82M
Increased by 18.22%
Revenue Next Year
118.90M
from 100.27M
Increased by 18.58%
EPS This Year
-0.47
from -0.49
EPS Next Year
-0.35
from -0.47
Year 2019202020212022202320242025202620272028
Revenue
-20.75M34.90M65.27M84.82M100.27M118.90M127.25M148.00M252.86M
Revenue Growth
--68.18%87.03%29.96%18.22%18.58%7.02%16.31%70.85%
EPS
-2.30-2.97-1.28-2.19-0.49-0.47-0.35-1.05-1.16-
EPS Growth
----------
No. Analysts -----86533
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 110.3M 139.7M 137.8M 153.2M 260.3M
Avg 100.3M 118.9M 127.3M 148.0M 252.9M
Low 93.6M 108.2M 113.4M 141.4M 242.9M

Revenue Growth

Revenue Growth 20242025202620272028
High
30.0%
39.3%
15.9%
20.4%
75.9%
Avg
18.2%
18.6%
7.0%
16.3%
70.9%
Low
10.3%
7.9%
-4.6%
11.1%
64.1%

EPS Forecast

EPS 2024202520262027
High -0.36 0.02 -0.92 -1.20
Avg -0.47 -0.35 -1.05 -1.16
Low -0.72 -0.78 -1.15 -1.12

EPS Growth

EPS Growth 2024202520262027
High - - - -
Avg - - - -
Low - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.